Products for Research Use Only
RegisterLogin

Oclacitinib-13C-d3

CAT: 0804-HY-13577SSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-13577SSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Oclacitinib-13C-d3 is the deuterium and 13C labeled Oclacitinib[1].
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Purity
99.0
Solubility
10 mM in DMSO|DMF : ≥ 14mg/mL|DMSO : ≥ 12mg/mL
Smiles
CNS(C[C@@H]1CC[C@H](CC1)N([13C]([2H])([2H])[2H])C2=NC=NC3=C2C=CN3)(=O)=O
Molecular Formula
C14 13CH20D3N5O2S
Molecular Weight
341.45
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-17410S2Iloperidone-13C, d3
HY-15463S3Imatinib-13C, d3
HY-10158S1Bosutinib-13C, d3
HY-10121S4-01Asenapine-d3,13C
HY-B0002BS2Ondansetron-13C, d3
HY-15651SAlvelestat-13C, d3
HY-113432S2Nudifloramide-13C, d3
HY-106827S1Trimegestone-13C, d3
HY-10219S1-01Rapamycin-13C, d3
HY-143848STadalafil-13C, d3

Alternative Products

CatalogName
CS-P-02272Oclacitinib-13C, d3
AR-O01029-01Oclacitinib-13C-d3
AR-N01607-01Nintedanib-13C-d3 (Intedanib-13C-d3)
AR-Y01012-01YM155-13C-d3 (Sepantronium-13C-d3 Bromide)
AR-E10376-01Erythromycylamine-13C-d3 (Dirithromycin EP Impurity A-13C-d3)
AR-P32603-01Pritelivir-13C-D3 (BAY 57-1293-13C-D3)
CS-CX-00633Vincamine-13C, d3
CS-EO-02379Vericiguat-13C, d3
CS-P-09079Thiocolchicoside-13C-d3
CS-O-15618Riociguat-13C, d3

Popular Products